Auto-Injector Market is Expected to Grow at 14.2% CAGR Till 2030

Pune, India, 31 January, 2023 Market Research Future has a half cooked research report on global auto-injector market. Global auto-injector market is growing rapidly and expected to continue its growth till the end of 2030.

Market Highlights

The auto-injector market is expected to reach USD 6,753.5 Million at 14.2% CAGR by 2030. Global Auto-Injector Market has been evaluated to be rapidly growing and expected to maintain this growth rate. Moreover, there is a huge possibility that the market will grow further in future. . Benefits such as easy self-administration, reduce dosage errors had increased growth of the market further. . Auto-injectors are widely accepted by patients suffering from disease like diabetes where regularly, fixed doses of insulin is required. Auto-injectors are also used where epinephrine is needed on regular basis.Out of total cases of food allergies worldwide, U.S. accounts for 6% of these cases while Europe accounts for 7.5% of food allergy cases. It is expected that number of these cases will increase in future which will consequently increase the growth of the global auto injector market. It was predicted that in May 2016, more than 80 auto-injectors will be developed which will be commercially available in the market by more than 20 companies. More than 50 drugs are being injected through auto-injectors which have been commercialized in 2016. 62% of the global auto injector’s market includes disposable auto injectors which proves beyond doubt their share in the global auto injector market.   

Companies are now focusing on introducing variety of advanced features to make auto-injectors more user friendly such as push-on-skin release, one handed operations, twist and mix mechanism, and others. Currently even the most advanced auto-injectors are being developed with Bluetooth connectivity, LCD screen and special software to connect the other devices, at the same time capable of delivering drug with high thickness. Some of these smart devices namely are Safella auto-injector (Namera), and SyrinaTM AR (Besbak). Some of the small companies which have entered the global auto injectors market recently with their innovative technologies includes Amedra Pharmaceuticals, ChemProtect SK, and Future Injections Technologies. Epinephrine auto-injector is commonly used and it is contributing maximum to the growth of global auto-injector market and is expected to grow at the CAGR of approx. 13% in future due to increasing cases of allergies which is the major reason for the growth of the epinephrine auto-injectors market.

Regional Analysis

Asia Pacific is expected to be the fastest growing market and is expected to maintain the same growth rate even in future. North America had the largest market share of 70% of the global auto-injector market in 2013 due to high prevalence of anaphylaxis and easy availability of auto-injectors owing to widespread healthcare infrastructure and government’s support to medical innovation. It is expected that global auto-injector market will grow further in future due to all these.  Explore In-depth Details: Auto-injector market research report

Global Auto-injector Market Players:

Major participants of this market are: SHL Group (US), Jiangsu Delfu medical device Co.,Ltd (China), Becton, Dickinson and Company (US), Novartis International AG (Switzerland), Pfizer Inc.(US), Ypsomed Holding AG (Switzerland), Unilife Corporation (US), and Owen Mumford (Oxford).

Segmentation:

The global auto-injector market is majorly segmented on the basis of technology, usage, application and end-users. Based on technology, the market is segmented into manual and automated auto-injectors. Based on usability market is segmented into disposable and reusable. Further on the basis of application the market is classified into arthritis, sclerosis, hormonal disorder and others. Similarly, on the basis of end-users the market is again classified into hospitals, research labs and centers, institutions and medical stores and others.